Crossmark

Elabela Peptide: A New Player in Hypertension and Vascular Damage

Crossref DOI link: https://doi.org/10.1007/s40292-022-00556-z

Published Online: 2022-12-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rubattu, Speranza https://orcid.org/0000-0002-9808-7970
License Information

Text and Data Mining valid from 2022-12-12

Version of Record valid from 2022-12-12
More Information

Article History

Accepted: 4 December 2022

First Online: 12 December 2022

Declarations

:

: There are no conflicts of interest to disclose.

: Not applicable.